BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harhala M, Nelson DC, Miernikiewicz P, Heselpoth RD, Brzezicka B, Majewska J, Linden SB, Shang X, Szymczak A, Lecion D, Marek-Bukowiec K, Kłak M, Wojciechowicz B, Lahutta K, Konieczny A, Dąbrowska K. Safety Studies of Pneumococcal Endolysins Cpl-1 and Pal. Viruses 2018;10:E638. [PMID: 30445722 DOI: 10.3390/v10110638] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Fernández L, Cima-Cabal MD, Duarte AC, Rodríguez A, García-Suárez MDM, García P. Gram-Positive Pneumonia: Possibilities Offered by Phage Therapy. Antibiotics (Basel) 2021;10:1000. [PMID: 34439050 DOI: 10.3390/antibiotics10081000] [Reference Citation Analysis]
2 Schmelcher M, Loessner MJ. Bacteriophage endolysins - extending their application to tissues and the bloodstream. Curr Opin Biotechnol 2021;68:51-9. [PMID: 33126104 DOI: 10.1016/j.copbio.2020.09.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Santos SB, Azeredo J. Bacteriophage-Based Biotechnological Applications. Viruses 2019;11:E737. [PMID: 31405109 DOI: 10.3390/v11080737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Álvarez A, Fernández L, Gutiérrez D, Iglesias B, Rodríguez A, García P. Methicillin-Resistant Staphylococcus aureus in Hospitals: Latest Trends and Treatments Based on Bacteriophages. J Clin Microbiol 2019;57:e01006-19. [PMID: 31578263 DOI: 10.1128/JCM.01006-19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Danis-Wlodarczyk KM, Wozniak DJ, Abedon ST. Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application. Antibiotics (Basel) 2021;10:1497. [PMID: 34943709 DOI: 10.3390/antibiotics10121497] [Reference Citation Analysis]
6 Ho MKY, Zhang P, Chen X, Xia J, Leung SSY. Bacteriophage endolysins against gram-positive bacteria, an overview on the clinical development and recent advances on the delivery and formulation strategies. Crit Rev Microbiol 2021;:1-24. [PMID: 34478359 DOI: 10.1080/1040841X.2021.1962803] [Reference Citation Analysis]
7 Xu D, Zhao S, Dou J, Xu X, Zhi Y, Wen L. Engineered endolysin-based "artilysins" for controlling the gram-negative pathogen Helicobacter pylori. AMB Express 2021;11:63. [PMID: 33913058 DOI: 10.1186/s13568-021-01222-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Aslam B, Arshad MI, Aslam MA, Muzammil S, Siddique AB, Yasmeen N, Khurshid M, Rasool M, Ahmad M, Rasool MH, Fahim M, Hussain R, Xia X, Baloch Z. Bacteriophage Proteome: Insights and Potentials of an Alternate to Antibiotics. Infect Dis Ther 2021;10:1171-93. [PMID: 34170506 DOI: 10.1007/s40121-021-00446-2] [Reference Citation Analysis]
9 Majewska J, Kaźmierczak Z, Lahutta K, Lecion D, Szymczak A, Miernikiewicz P, Drapała J, Harhala M, Marek-Bukowiec K, Jędruchniewicz N, Owczarek B, Górski A, Dąbrowska K. Induction of Phage-Specific Antibodies by Two Therapeutic Staphylococcal Bacteriophages Administered per os. Front Immunol 2019;10:2607. [PMID: 31803179 DOI: 10.3389/fimmu.2019.02607] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
10 Gondil VS, Harjai K, Chhibber S. Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections. Int J Antimicrob Agents 2020;55:105844. [PMID: 31715257 DOI: 10.1016/j.ijantimicag.2019.11.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
11 De Maesschalck V, Gutiérrez D, Paeshuyse J, Lavigne R, Briers Y. Advanced engineering of third-generation lysins and formulation strategies for clinical applications. Crit Rev Microbiol 2020;46:548-64. [PMID: 32886565 DOI: 10.1080/1040841X.2020.1809346] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
12 Chang Y. Bacteriophage-Derived Endolysins Applied as Potent Biocontrol Agents to Enhance Food Safety. Microorganisms 2020;8:E724. [PMID: 32413991 DOI: 10.3390/microorganisms8050724] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
13 Kwiatek M, Parasion S, Nakonieczna A. Therapeutic bacteriophages as a rescue treatment for drug-resistant infections - an in vivo studies overview. J Appl Microbiol 2020;128:985-1002. [PMID: 31778593 DOI: 10.1111/jam.14535] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
14 Grabowski Ł, Łepek K, Stasiłojć M, Kosznik-Kwaśnicka K, Zdrojewska K, Maciąg-Dorszyńska M, Węgrzyn G, Węgrzyn A. Bacteriophage-encoded enzymes destroying bacterial cell membranes and walls, and their potential use as antimicrobial agents. Microbiol Res 2021;248:126746. [PMID: 33773329 DOI: 10.1016/j.micres.2021.126746] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Silva MD, Oliveira H, Faustino A, Sillankorva S. Characterization of MSlys, the endolysin of Streptococcus pneumoniae phage MS1. Biotechnol Rep (Amst) 2020;28:e00547. [PMID: 33204659 DOI: 10.1016/j.btre.2020.e00547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Harhala M, Gembara K, Miernikiewicz P, Owczarek B, Kaźmierczak Z, Majewska J, Nelson DC, Dąbrowska K. DNA Dye Sytox Green in Detection of Bacteriolytic Activity: High Speed, Precision and Sensitivity Demonstrated With Endolysins. Front Microbiol 2021;12:752282. [PMID: 34759903 DOI: 10.3389/fmicb.2021.752282] [Reference Citation Analysis]
17 Salas M, Wernecki M, Fernández L, Iglesias B, Gutiérrez D, Álvarez A, García L, Prieto E, García P, Rodríguez A. Characterization of Clinical MRSA Isolates from Northern Spain and Assessment of Their Susceptibility to Phage-Derived Antimicrobials. Antibiotics (Basel) 2020;9:E447. [PMID: 32722499 DOI: 10.3390/antibiotics9080447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Gutiérrez D, Garrido V, Fernández L, Portilla S, Rodríguez A, Grilló MJ, García P. Phage Lytic Protein LysRODI Prevents Staphylococcal Mastitis in Mice. Front Microbiol 2020;11:7. [PMID: 32038593 DOI: 10.3389/fmicb.2020.00007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
19 Murray E, Draper LA, Ross RP, Hill C. The Advantages and Challenges of Using Endolysins in a Clinical Setting. Viruses 2021;13:680. [PMID: 33920965 DOI: 10.3390/v13040680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]